GE HealthCare and Tribun Health collaboration helps foster enterprise imaging and pathology for oncology

GE HealthCare announced today that Sant’ Andrea University Hospital, a center of excellence affiliated with Sapienza University of Rome, has  chosen the combined strength of GE HealthCare’s Enterprise Imaging platform and Tribun Health’s CaloPix® digital pathology solution to unify radiology and pathology into a seamless integrated, artificial intelligence (AI) ready environment.

With GE HealthCare’s Datalogue, including a vendor neutral archive (VNA), and Tribun Health’s award winning digital pathology platform  CaloPix®, Sant’ Andrea is driving to the forefront of a new era in data driven cancer care. GE HealthCare’s Datalogue helps unify and intelligently  manage patient data, images and enterprise imaging content. The Tribun Health Suite is a leading AI-powered end-to-end computational pathology  for diagnostics, prognosis and drug development.

Sant’ Andrea, a public university hospital known for its leadership in oncology and translational research, manages a high volume of complex  pathology and imaging cases. This initiative supports its broader mission of accelerating diagnostics, advancing multidisciplinary collaboration, and improving outcomes for patients facing cancer. Sant’ Andrea Hospital is the first in Lazio to implement full digital pathology, with an investment of  nearly €1.5 million, about €800,000 of which came from the National Recovery and Resilience Plan.

“The oncology care pathway is one of the most complex with multiple steps involving a variety of specialists, complex tools, frequent decisions and  large data sets,” said Scott Miller, CEO of Solutions for Enterprise Imaging, GE HealthCare. “Sant’ Andrea’s enterprise imaging implementation will help streamline the oncology care pathway across the enterprise and support clinical teams delivering the best care to their patients.”

“This marks a significant achievement for both Tribun Health and GE HealthCare, and a promising step forward for the future of diagnostic  medicine,” said Jean-François Pomerol, CEO of Tribun Health. “Through this collaboration, we’re demonstrating how global partnerships can drive measurable local impact—enhancing efficiency in pathology  labs, improving clinical decision-making, and accelerating the delivery of critical insights to patients undergoing cancer care.”

The digital pathology solutions will help focus on making pathology diagnostic faster and easier for healthcare providers at the point of care. With  GE HealthCare’s Datalogue, pathology diagnostic outputs are integrated into an enterprise imaging platform, and can help create a one stop shop  for unified clinical data available to clinicians to form decisions. A unified view of clinical patient data is a key asset in oncology for a multi- disciplinary team to be powered by the patient related information and collaborate to define best treatment for the patient in the oncology care  pathway.

“This implementation allows doctors to make faster, more informed decisions and represents a fundamental step in our hospital’s digital transformation,” said Francesca Milito, General Director of AOU Sant’ Andrea. “By unifying radiology and pathology, we improve access to clinical  data and create an integrated environment where doctors can make faster and more informed decisions for every cancer patient.”

About GE HealthCare Technologies Inc.

GE HealthCare is a trusted partner and leading global healthcare solutions provider, innovating medical technology, pharmaceutical diagnostics,  and integrated, cloud-first AI-enabled solutions, services and data analytics. We aim to make hospitals and health systems more efficient, clinicians  more effective, therapies more precise, and patients healthier and happier. Serving patients and providers for more than 125 years, GE HealthCare  is advancing personalized, connected and compassionate care, while simplifying the patient’s journey across care pathways. Together, our Imaging,  Advanced Visualization Solutions, Patient Care Solutions and Pharmaceutical Diagnostics businesses help improve patient care from screening and  diagnosis to therapy and monitoring. We are a $19.7 billion business with approximately 53,000 colleagues working to create a world where  healthcare has no limits.

About Tribun Health

Tribun Health is a global leader in digital pathology. Its CaloPix® platform, awarded Best in KLAS, CE marked, approved by Health Canada, and  authorized by the FDA, helps laboratories improve workflow efficiency and diagnostic accuracy. We shape the future of pathology through digital  technology, AI, and data — to ensure each patient receives a fair and rapid diagnosis, and to give pathologists the tools they need to make crucial  decisions with confidence.